Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the Pharmacokinetics and Safety / Tolerability of Fimasartan and Atorvastatin in Healthy Male volunteers.

Clinical Trial Description

This is a randomized, open-label, single dose, 3x3 partial replicated crossover study to evaluate the pharmacokinetics and safety/tolerability. Within each period, randomized subjects will be 2 dosing regimens with a fixed dose combination of Fimasartan/Atorvastatin and co-administration of Fimasartan and Atorvastatin. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT02994745
Study type Interventional
Source Boryung Pharmaceutical Co., Ltd
Status Completed
Phase Phase 1
Start date December 23, 2016
Completion date August 2017

See also
  Status Clinical Trial Phase
Completed NCT01918709 - Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers Phase 1
Active, not recruiting NCT03847506 - Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets Phase 4
Completed NCT02995720 - A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin Phase 1